Safety and Tolerability of Rituxan With Methotrexate and Etanercept or Methotrexate and Adalimumab in Patients With Active Rheumatoid Arthritis
Clinical trial NCT00298272 · TERMINATED
Trial details
- NCT number
- NCT00298272
- Sponsor
- Biogen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2009-04-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.